Skip to content

Comparison of the Effects of Trigonum Femoral + Distal Adductor Block and Adductor Canal + N.Tibialis Posterior Block on Postoperative Pain in Total Knee Replacement Surgery: A Multicenter Study

Comparison of the Effects of Trigonum Femoral + Distal Adductor Block and Adductor Canal + N.Tibialis Posterior Block on Postoperative Pain in Total Knee Replacement Surgery: A Multicenter Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000827437
Enrollment
30
Registered
2025-08-01
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

It is aimed to compare the effects of Trigonum Femoral + Distal Adductor Block and Adductor Canal + N.Tibialis Posterior Blocks on Postoperative Pain in Total Knee Replacement Surgery. pain scores and additional analgesic requirements will be measured in patients after these blocks. effects of block combinations, pain scores, additional analgesic requirements and complications will be evaluated.

Interventions

The study is planned to be conducted prospectively and multicenter after approval from the Clinical Research and Ethics Committee of Kahramanmaras Sütçü Imam University Health Practice and Research Hospital. Patients were randomly divided into 2 groups as Femoral Triangle Nerve Block + Distal Adductor Canal Block (Group A) and Adductor Canal Block + Tibialis Posterior Nerve Block (Group B) and Patient Controlled Analgesia (PCA) will be applied to both groups. Pat

The study is planned to be conducted prospectively and multicenter after approval from the Clinical Research and Ethics Committee of Kahramanmaras Sütçü Imam University Health Practice and Research Hospital. Patients were randomly divided into 2 groups as Femoral Triangle Nerve Block + Distal Adductor Canal Block (Group A) and Adductor Canal Block + Tibialis Posterior Nerve Block (Group B) and Patient Controlled Analgesia (PCA) will be applied to both groups. Patients' oral intake will be stopped 8 hours before surgery as we routinely do in our clinic. All of our patients will be informed about the VAS questionnaire preoperatively so that various postoperative pain treatment methods can be applied. Patients admitted to the operating table will be monitored for heart rate, 3-lead ECG and pulse oximetry (SpO2) values, and vascular access will be established using a 20G catheter through the dorsum of the hand. While the patients are in the sitting position, aseptic conditions will be ensured and a 25 G Quincke spinal needle will be advanced through the appropriate intervertebral space (L3-L4 or L4-L5), passing through the skin, subcutaneous supraspinal ligament, interspinous ligament, ligamentum flavum, epidural space and dura to the subarachnoid space, and when it reaches the subarachnoid space, the chuck will be withdrawn and the free flow of spinal fluid will be observed. Then heavy marcain will be administered, the dose of which is determined according to the patient's height. After the level of sensory block is checked by pin prick test and motor block is checked by Bromage method, the operation will be started. In the last half hour of the operation, 100 mg tramadol+1 g paracetamol IV will be administered to the patients of both groups. At the end of the operation, patients will be taken to the operating room postoperative recovery room. Patients in Group A will undergo Ultrasound guided Femoral Triangle Nerve + Distal Adductor technique block postoperatively by anesthesiologist (specialist) . The same volume of local anesthetic will be used in the groups, “10 mL bupivacaine 0.25%” for a single block type and “20 mL bupivacaine 0.25%” in total. After the blocks are performed, patient-controlled analgesia (PCA) will be applied to the patients from the recovery room and they will be followed up with a data monitoring form. Age, gender, body mass index, ASA scores, duration of surgery and preoperative VAS values will be recorded. IV patient-controlled analgesia with 1 mg/cc tramadol will be started in the postoperative period. The bolus dose will be 20 mg without basal infusion and the lock time will be set to 15 min. When VAS values exceed 4 in patient follow-up, 75 mg diclofenac sodium IM will be administered as rescue analgesic and recorded as additional analgesic requirement. Patients will be visited in the ward at 8, 12, and 24 hours postoperatively; the first time they used the patient-controlled pain device, the values obtained with the visual analog scale (VAS with 0-10 cm scale), and the 24-hour tramadol consumption of all patients in milligrams and the additional analgesic demand will be recorded on the postoperative follow-up forms. Patients' satisfaction levels at the end of the 24th hour will also be assessed with a four-point Likert scale (very good, good, fair, and poor) and quality of recovery will be assessed with the QOR-15 questionnaire.

Sponsors

ege university
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients between 18-80 years of age who will undergo knee prosthesis surgery 2. ASA I-III patients 3. Patients with full orientation-cooperation and communication 4. Patients whose surgery was completed under spinal anesthesia

Exclusion criteria

1.Patients allergic to local anesthetics and/or drugs used in the study 2. Patients whose patient-controlled anesthesia device is out of use for any reason within the first 24 hours postoperatively 3. Patients with peripheral neuropathy or neuromuscular disease 4. Patients with anticoagulant drug use and bleeding profile disorders that would prevent regional anesthesia

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026